Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
Study Information
Alliance Study ID: A091102
NCT Study ID (ClinicalTrials.gov): NCT01653028
Alliance Committee: Experimental Therapeutics
Disease or Cancer Type: Sarcoma & Soft Tissue / Bone Cancers
Alliance Study Chair: Mark Dickson
Status: COMPLETED
Study Description
This phase II trial studies how well alisertib works in treating patients with sarcoma that has spread to other places in the body and usually cannot be cured or controlled with treatment (advanced) or has spread to other places in the body (metastatic). Alisertib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information